Who Paid My Doc Search
Menu
Organisation paid for research Program year 2023 Source: CMS Open Payments

Suncoast Research Group

Neither a doctor nor a teaching hospital

Research payments

$284,452

69 payments

Through program year 2023, Suncoast Research Group is reported as receiving $284,452 in research payments, across 69 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $8,730 3
2022 Research $23,103 4
2021 Research $183,036 5
2020 Research $55,094 30
2019 Research $14,489 27

Breakdown

Who paid Research payments · program years 2019–2023
  1. Novartis Pharmaceuticals Corporation $213,661 5 payments
  2. Jazz Pharmaceuticals Inc. $52,324 43 payments
  3. Pfizer Inc. $17,053 19 payments
  4. Amgen Inc. $1,414 2 payments
Studies the money was for Research payments · program years 2019–2023
  1. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ensovibep (Mp0420) in Ambulatory Adult Patients With Symptomatic Covid-19 (The Empathy Trial) $178,726 1 payment
  2. A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of Jzp-258 in the Treatment of Idiopathic Hypersomnia (Ih) With An Open-Label Safety Extension $52,324 43 payments
  3. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ensovibep (Mp0420) in Ambulatory Adult Patients With Symptomatic Covid-19 $21,990 1 payment
  4. Observational Registry of Treatment Patterns in US Heart Failure Patients With Reduced Ejection Fraction $12,945 3 payments
  5. A Study to Evaluate the Safety Tolerability and Immunogenicity of Combined Vaccine Candidates Against Infectious Respiratory Illnesses Including Covid19 and RSV in Healthy Individuals $6,784 1 payment
  6. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccinenaive Adults 18 Years of Age and Older $3,306 9 payments
  7. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine 20Vpnc When Coadministered With Seasonal Inactivated Influenza Vaccine Siiv in Adults 65 Years of Age $2,644 1 payment
  8. A Study to Evaluate the Safety Tolerability and Immunogenicity of Combined Vaccine Candidates Against Infectious Respiratory Illnesses Including Covid19 and RSV in Healthy Individuals $1,946 2 payments
  9. A Phase 23 Randomized Doubleblind Doubledummy Placebo Controlled Study to Evaluate the Safety and Efficacy of 2 Regimens of Orally Administered PF 07321332Ritonavir in Preventing Symptomatic Sarscov2 Infection in Adult Household Contacts of An Individual With Symptomatic Covid19 $1,456 5 payments
  10. Gould $1,030 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record